Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Madsen RR"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hillis AL; Department of Pathology and Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Martin TD; Division of Genetics, Department of Genetics, Brigham and Women's Hospital, Howard Hughes Medical Institute, Harvard Medical School, Boston, Massachusetts., Manchester HE; Genetics Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Högström J; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Zhang N; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Lecky E; Department of Pathology and Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Kozlova N; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Lee J; Preclinical Murine Pharmacogenetics Facility and Mouse Hospital, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Persky NS; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Root DE; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Brown M; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Cichowski K; Genetics Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Elledge SJ; Division of Genetics, Department of Genetics, Brigham and Women's Hospital, Howard Hughes Medical Institute, Harvard Medical School, Boston, Massachusetts., Muranen T; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Fruman DA; Department of Molecular Biology and Biochemistry, University of California, Irvine, California., Barry ST; Bioscience, Discovery, Oncology Research and Development, AstraZeneca, Cambridge, Massachusetts., Clohessy JG; Preclinical Murine Pharmacogenetics Facility and Mouse Hospital, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Madsen RR; MRC-Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, United Kingdom., Toker A; Department of Pathology and Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Publikováno v:
Cancer research [Cancer Res] 2024 Oct 01; Vol. 84 (19), pp. 3250-3266.
Autor:
Erickson EC; Department of Pathology, Medicine and Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02215, USA., You I; Department of Chemical and Systems Biology, Stanford University, Stanford, CA 94305, USA., Perry G; Department of Pathology, Medicine and Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA., Dugourd A; Faculty of Medicine, and Heidelberg University Hospital, Institute for Computational Biomedicine, Heidelberg University, Heidelberg 69120, Germany., Donovan KA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02215, USA.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Crafter C; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, UK., Johannes JW; Research and Early Development, Oncology R&D, AstraZeneca, Waltham, MA 02451, USA., Williamson S; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, UK., Moss JI; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, UK., Ros S; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, UK., Ziegler RE; Research and Early Development, Oncology R&D, AstraZeneca, Waltham, MA 02451, USA., Barry ST; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, UK., Fischer ES; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02215, USA.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Gray NS; Department of Chemical and Systems Biology, Stanford University, Stanford, CA 94305, USA., Madsen RR; University College London Cancer Institute, Paul O'Gorman Building, University College London, London WC1E 6BT, UK., Toker A; Department of Pathology, Medicine and Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Publikováno v:
Science signaling [Sci Signal] 2024 Feb 27; Vol. 17 (825), pp. eadf2670. Date of Electronic Publication: 2024 Feb 27.
Autor:
Madsen RR; MRC-Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, Scotland, United Kingdom. Electronic address: rmadsen001@dundee.ac.uk., Toker A; Department of Pathology and Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: atoker@bidmc.harvard.edu.
Publikováno v:
The Journal of biological chemistry [J Biol Chem] 2023 Oct; Vol. 299 (10), pp. 105224. Date of Electronic Publication: 2023 Sep 09.
Autor:
Gong GQ; Cell Signalling, Cancer Institute, University College London, London, UK., Bilanges B; Cell Signalling, Cancer Institute, University College London, London, UK., Allsop B; Drug Discovery Group, Translational Research Office, University College London, London, UK., Masson GR; Medical Research Council Laboratory of Molecular Biology, Cambridge, UK.; Division of Cellular Medicine, School of Medicine, University of Dundee, Dundee, UK., Roberton V; UCL Centre for Nerve Engineering, UCL School of Pharmacy, University College London, London, UK., Askwith T; Drug Discovery Group, Translational Research Office, University College London, London, UK., Oxenford S; Drug Discovery Group, Translational Research Office, University College London, London, UK., Madsen RR; Cell Signalling, Cancer Institute, University College London, London, UK., Conduit SE; Cell Signalling, Cancer Institute, University College London, London, UK., Bellini D; Medical Research Council Laboratory of Molecular Biology, Cambridge, UK., Fitzek M; Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Alderley Park, Macclesfield, UK., Collier M; Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Alderley Park, Macclesfield, UK., Najam O; The Hatter Cardiovascular Institute, University College London, London, UK., He Z; The Hatter Cardiovascular Institute, University College London, London, UK., Wahab B; Medicines Discovery Institute, School of Biosciences, Cardiff University, Cardiff, UK., McLaughlin SH; Medical Research Council Laboratory of Molecular Biology, Cambridge, UK., Chan AWE; Wolfson Institute for Biomedical Research, University College London, London, UK., Feierberg I; Molecular AI, Discovery Sciences, R&D, AstraZeneca, Waltham, MA, USA., Madin A; Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK., Morelli D; Cell Signalling, Cancer Institute, University College London, London, UK., Bhamra A; Proteomics Research Translational Technology Platform, Cancer Institute, University College London, London, UK., Vinciauskaite V; Division of Cellular Medicine, School of Medicine, University of Dundee, Dundee, UK., Anderson KE; Signalling Programme, Babraham Institute, Cambridge, UK., Surinova S; Proteomics Research Translational Technology Platform, Cancer Institute, University College London, London, UK., Pinotsis N; Institute of Structural and Molecular Biology, Birkbeck College, London, UK., Lopez-Guadamillas E; Cell Signalling, Cancer Institute, University College London, London, UK., Wilcox M; UCL Centre for Nerve Engineering, UCL School of Pharmacy, University College London, London, UK., Hooper A; Drug Discovery Group, Translational Research Office, University College London, London, UK., Patel C; Drug Discovery Group, Translational Research Office, University College London, London, UK., Whitehead MA; Cell Signalling, Cancer Institute, University College London, London, UK., Bunney TD; Institute of Structural and Molecular Biology, Division of Biosciences, University College London, London, UK., Stephens LR; Signalling Programme, Babraham Institute, Cambridge, UK., Hawkins PT; Signalling Programme, Babraham Institute, Cambridge, UK., Katan M; Institute of Structural and Molecular Biology, Division of Biosciences, University College London, London, UK., Yellon DM; The Hatter Cardiovascular Institute, University College London, London, UK., Davidson SM; The Hatter Cardiovascular Institute, University College London, London, UK., Smith DM; Emerging Innovations, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK., Phillips JB; UCL Centre for Nerve Engineering, UCL School of Pharmacy, University College London, London, UK., Angell R; Drug Discovery Group, Translational Research Office, University College London, London, UK.; Medicines Discovery Institute, School of Biosciences, Cardiff University, Cardiff, UK., Williams RL; Medical Research Council Laboratory of Molecular Biology, Cambridge, UK., Vanhaesebroeck B; Cell Signalling, Cancer Institute, University College London, London, UK. bart.vanh@ucl.ac.uk.
Publikováno v:
Nature [Nature] 2023 Jun; Vol. 618 (7963), pp. 159-168. Date of Electronic Publication: 2023 May 24.
Autor:
Madsen RR; University College London (UCL) Cancer Institute, Paul O'Gorman Building, University College London, 72 Huntley Street, London WC1E 6DD, UK., Semple RK; Centre for Cardiovascular Sciences, Queen's Medical Research Institute, University of Edinburgh, Little France Crescent, Edinburgh EH16 4TJ, UK. Electronic address: rsemple@exseed.ed.ac.uk.
Publikováno v:
Trends in molecular medicine [Trends Mol Med] 2022 Apr; Vol. 28 (4), pp. 255-257. Date of Electronic Publication: 2022 Mar 08.
Autor:
Vanhaesebroeck B; University College London Cancer Institute, University College London, London, United Kingdom. bart.vanh@ucl.ac.uk., Burke JE; Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada.; Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia, Canada., Madsen RR; University College London Cancer Institute, University College London, London, United Kingdom.
Publikováno v:
Cancer discovery [Cancer Discov] 2022 Jan; Vol. 12 (1), pp. 20-22.
Autor:
Madsen RR; University College London Cancer Institute, Paul O'Gorman Building, University College London, London, United Kingdom., Erickson EC; Department of Pathology, Medicine and Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America., Rueda OM; Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom.; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom.; NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom., Robin X; SIB Swiss Institute of Bioinformatics, Biozentrum, University of Basel, Basel, Switzerland., Caldas C; Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom.; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom.; NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom., Toker A; Department of Pathology, Medicine and Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America., Semple RK; Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom., Vanhaesebroeck B; University College London Cancer Institute, Paul O'Gorman Building, University College London, London, United Kingdom.
Publikováno v:
PLoS genetics [PLoS Genet] 2021 Nov 11; Vol. 17 (11), pp. e1009876. Date of Electronic Publication: 2021 Nov 11 (Print Publication: 2021).
Autor:
Madsen RR; Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, Edinburgh EH16 4TJ, UK.; Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge CB2 0QQ, UK.; The National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge CB2 0QQ, UK., Longden J; Biotech Research and Innovation Centre, University of Copenhagen, DK-2200 Copenhagen, Denmark.; Theoretical Biophysics, Institute of Biology, Humboldt-Universität zu Berlin, 10115 Berlin, Germany., Knox RG; Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge CB2 0QQ, UK.; The National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge CB2 0QQ, UK., Robin X; Biotech Research and Innovation Centre, University of Copenhagen, DK-2200 Copenhagen, Denmark., Völlmy F; Biotech Research and Innovation Centre, University of Copenhagen, DK-2200 Copenhagen, Denmark., Macleod KG; Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK., Moniz LS; University College London Cancer Institute, Paul O'Gorman Building, University College London, London WC1E 6BT, UK., Carragher NO; Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK., Linding R; Biotech Research and Innovation Centre, University of Copenhagen, DK-2200 Copenhagen, Denmark.; Theoretical Biophysics, Institute of Biology, Humboldt-Universität zu Berlin, 10115 Berlin, Germany., Vanhaesebroeck B; University College London Cancer Institute, Paul O'Gorman Building, University College London, London WC1E 6BT, UK., Semple RK; Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, Edinburgh EH16 4TJ, UK.
Publikováno v:
Disease models & mechanisms [Dis Model Mech] 2021 Mar 01; Vol. 14 (3). Date of Electronic Publication: 2021 Mar 11.